Commenters concerned about scope of FDA’s BsUFA regulatory science pilot
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesNorth AmericaProduct LifecycleRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesNorth AmericaProduct Lifecycle